3 Stocks Under Investors' Clench - ECT, BGS And MXC

While the investors were getting concerned over the few declining sessions in the market, the energy sectors’ rebound helped ASX to close higher at 5736 and all ordinaries at 5825. Here are three stocks under the investor’s eyes. This is a good mix of stocks from different sectors to look at.

ENVIRONMENTAL CLEAN TECHNOLOGIES LIMITED (ASX: ECT) – The company in August 2018, for $4 million on the same terms and conditions as the previous facility signed a new Secured Loan Agreement with Brevet for the 2018/19 financial year. The loss for the consolidated entity after providing for income tax amounted to $5,133,685 compared to 30 June 2017 loss of $4,357,282, there were no dividends paid, recommended or declared during the current or previous financial year. The net current assets at the reporting date of $145,046 compared to 2017 net current liabilities of $311,162. The company has advised that the board of NLC India Limited has approved the Research Collaboration Agreement for the Company’s India project. The stock is trading flat at $0.014 as at November 15, 2018. Over the past 12 months period the stock has witnessed a performance change of 55.56%.Â

BIRIMIAN LIMITED (ASX: BGS) – With payment of the initial NSR royalty payment of US$280,428 the company received its first mining revenue in early August 2018, compared to A$377,122 during the June Quarter 2018 from Morila for gold produced at the N’tiola Area of Interest. The stock has lower earnings per share (EPS) of -0.029 AUD which reflects the restrained profitability. The cash and cash equivalents at end of period $4.908 million and the company has no debt facility which represents healthy balance sheet and also a working capital surplus of $6,840,152 as compared to December 2017 surplus of $11,546,975. The stock is trading flat at $0.200 as at November 15, 2018. Over the past 60 months period the stock has witnessed a performance change of 70.51%.

MGC PHARMACEUTICALS LTD (ASX: MXC) – To sell 100% of MGC Derma to Canadian private cannabis investment company, the company has signed a formal definitive agreement, trading as CannaGlobal, Cannaglobal Canada Co Inc, following the signing of a Binding Term Sheet. The consolidated loss of the Group from continued operations amounted to $8,990,470 compared to 2017 loss of $8,502,025 following which no dividends have been paid or declared for payment during, or since, the end of the financial year. The year-end cash and cash equivalents balance of $9,858,977 lesser than 2017 cash of $11,363,902. The stock is trading flat at $0.039 as at November 15, 2018 which is very close to its 52-week low. Over the past 60 months period the stock has witnessed a performance change of 330.00%.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Â


Disclaimer
The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK